ZNF148 and breast carcinoma: Next, PicTar (www.pictar.org), TargetScan (www.targetscan.org) and miRanda (www.microrna.org) prediction software suggested that miR‐335 was downstream of ZNF‐148 (Figure 4E), and a dual‐luciferase reporter assay demonstrated that miR‐335 is a target of ZNF‐148 in breast cancer cells (Figure 4F,G).